iShares
EXV4.DE
DE000A0Q4R36
iShares STOXX Europe 600 Health Care UCITS ETF (DE)
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
21.48
Weighted Fwd P/E
17.73
Avg P/FCF
22.09
Avg FCF Yield
4.22%
Avg EV / EBITDA
14.88
Avg EV / Revenue
9.91
Avg Price-to-Book (P/B)
96.98
Avg Price-to-Sales (P/S)
10.57
Avg Dividend Yield
0.02%
P/E Compression (Trailing vs Fwd)
-17.46%
Avg Debt-to-Equity (D/E)
73.08%
<50% (23.68%) 50-150% (75.31%) >150% (0.77%) Unreported (0.24%)

Profitability Analysis

46 Holdings Count
Profitable 99.59%
Profitable 99.59%
45 Holdings Count (97.83%)
Unprofitable 0.41%
1 Holdings Count (2.17%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

High Concentration (Top-Heavy)
Top 5
56.7%
Top 10
73.6%
Top 25
92.6%
50% Threshold
Top 4
The top 10 holdings account for 73.6% of the total ETF. Performance is heavily driven by a few heavyweights. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

12 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (10.3%+)
High (26.7%+)
Top (37.0%+)

Country Breakdown

Max: 41.11%
CH CH CH
41.11%
GB GB GB
21.60%
DK DK DK
11.04%
FR FR FR
9.41%
DE DE DE
6.74%
NL NL NL
4.90%
BE BE BE
1.88%
SE SE SE
1.10%
FI FI FI
0.52%
LU LU LU
0.49%
IT IT IT
0.35%
ES ES ES
0.18%

Sector Distribution

2 Sector
Healthcare
98.04%
Basic Materials
1.27%

Industry Distribution

8 Industries
Drug Manufacturers - General
65.73%
Drug Manufacturers - Specialty & Generic
8.71%
Biotechnology
7.10%
Medical Instruments & Supplies
7.07%
Medical Devices
4.05%
Diagnostics & Research
3.79%
Medical Care Facilities
1.59%
Specialty Chemicals
1.27%

Market Cap Distribution

46 Holdings Count
Mega Cap (> 200B)
(3) 43.94%
Large Cap (10B - 200B)
(30) 52.07%
Mid Cap (2B - 10B)
(13) 3.29%
ende